ENSIFENTRINE, A NOVEL COPD TREATMENT, REDUCED COPD-RELATED HEALTHCARE RESOURCE UTILIZATION OVER 48 WEEKS

被引:0
|
作者
Wan, Emily
Rheault, Tara
Dixon, Amy
Reyner, Daniel
Rickard, Kathleen A.
机构
关键词
D O I
10.1016/j.chest.2024.06.2945
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:4964A / 4965A
页数:2
相关论文
共 50 条
  • [1] ENSIFENTRINE, AN INVESTIGATIONAL, INHALED PDE3/4 INHIBITOR, DECREASED COPD-RELATED HEALTHCARE RESOURCE UTILIZATION OVER 24 WEEKS
    Wan, E.
    Rickard, K.
    Dixon, A.
    Davidson, J.
    Galloway, S.
    Rheault, T.
    VALUE IN HEALTH, 2024, 27 (06) : S49 - S49
  • [2] Ensifentrine as a novel treatment for COPD-related symptoms: a comprehensive overview of clinical trials
    Victor Oluwatomiwa Ajekiigbe
    Ikponmwosa Jude Ogieuhi
    Christopher Abiodun Adegbesan
    Emmanuel Oyetola
    Oluwatobiloba Samson Fakojo
    Kaleb Lema
    Tolulope Felix Omitade
    Marvellous Inioluwa Adepoju
    Abdulsalam Oladoja Owonikoko
    Kamil-Bello Faisol Olabisi
    Chidera Stanley Anthony
    Discover Medicine, 1 (1):
  • [3] Inhaled Ensifentrine, decreased healthcare research utilization and reduced moderate exacerbation rate and risk in COPD over 24 Weeks
    Watz, Henrik
    Rheault, Tara
    Bengtsson, Thomas
    Rickard, Kathleen
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea
    Chung, Kyungsoo
    Kim, Kyungjoo
    Jung, Jiye
    Oh, Kyungwon
    Oh, Yeonmok
    Kim, Sekyu
    Kim, Jinhee
    Kim, Youngsam
    BMC PULMONARY MEDICINE, 2014, 14
  • [5] Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea
    Kyungsoo Chung
    Kyungjoo Kim
    Jiye Jung
    Kyungwon Oh
    Yeonmok Oh
    Sekyu Kim
    Jinhee Kim
    Youngsam Kim
    BMC Pulmonary Medicine, 14
  • [6] Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD
    Donohue, James F.
    Rheault, Tara
    MacDonald-Berko, Margot
    Bengtsson, Thomas
    Rickard, Kathleen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 1611 - 1622
  • [7] Geographic and Payer Variation in the Prevalence, Demographics, and COPD-related Hospital Utilization of Patients With COPD
    Feigler, N.
    Bazell, C.
    Alston, M.
    Chung, Y.
    Leary, S.
    McCarthy, A.
    Komanduri, S.
    Fopalan, W.
    Mannino, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] Ensifentrine Reduced Healthcare Resource Utilization in Subjects With COPD: Results From Enhance-2, a Phase 3 Trial of Ensifentrine, a Dual PDE3/4 Inhibitor
    Barjaktarevic, I.
    Rheault, T.
    Bengtsson, T.
    Rickard, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] IMPACT OF BENRALIZUMAB ON ASTHMA AND COPD EXACERBATION-RELATED HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH ASTHMA AND CONCOMITANT COPD
    Carstens, D.
    Maselli, D. J.
    Chen, J.
    Cook, E.
    Mu, F.
    Yang, D.
    Chung, Y.
    VALUE IN HEALTH, 2024, 27 (06) : S138 - S138
  • [10] COPD-RELATED HEALTHCARE RESOURCE UTILIZATION BEFORE AND AFTER INITIATING INHALED CORTICOSTEROID-CONTAINING MAINTENANCE REGIMENS: REAL WORLD CLAIMS DATA
    Siddharthan, T.
    Lamprey, C.
    Aggarwal, K.
    Pan, Y.
    Tejwani, V
    VALUE IN HEALTH, 2024, 27 (06) : S60 - S61